on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Lytham Partners Healthcare Summit
Jaguar Health, Inc. (NASDAQ: JAGX) announced that its founder, president, and CEO, Lisa Conte, will present virtually at the Lytham Partners Healthcare Investor Summit on January 15, 2026. The presentation is scheduled for 3:30 PM Eastern and will offer updates on Jaguar Health's near-term catalysts. A replay will be accessible through the designated conference link.
Jaguar Health is a commercial stage pharmaceutical company focused on developing prescription medicines derived from rainforest plants. These products target gastrointestinal distress, including conditions such as chronic diarrhea and bowel incontinence. The company's subsidiary, Napo Pharmaceuticals, markets crofelemer, an FDA-approved treatment for noninfectious diarrhea in adults with HIV/AIDS.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news